Patents
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
11/1983
11/01/1983US4412985 Depyrogenation process
11/01/1983US4412946 Immunostimulating glycoproteins
10/1983
10/27/1983WO1983003679A1 Antibodies having dual specificities, their preparation and uses therefor
10/27/1983WO1983003623A1 CODING DNA FRAGMENTS FOR POLYPEPTIDES CONTAINING AT LEAST ONE ANTIGENIC DETERMINANT OF THE PAPILLOMAVIRUS PARTICULARLY OF THE 1a HPV TYPE AND CORRESPONDING POLYPEPTIDES
10/27/1983WO1983003547A1 Synthetic picornavirus antigen
10/27/1983WO1983003546A1 Temperature sensitive reassortant viruses and a vaccine against equine influenza
10/26/1983EP0092456A1 DNA fragments encoding for polypeptides containing at least an antigenic determinant of Papilloma viruses, notably of the HPV 1A-type, and corresponding polypeptides
10/26/1983EP0092249A2 Non-A, non-B hepatitis-associated monoclonal antibody and diagnostic reagent
10/26/1983EP0092223A2 Cytosole-CEA-measurement as predictative test in carcinoma, particularly mammacarcinoma
10/26/1983EP0092186A2 Method of preparing gamma globulin suitable for intravenous administration
10/26/1983EP0091958A1 Liposome conjugates and diagnostic methods therewith
10/25/1983US4411993 Antitumor and -carcinogenic agents
10/25/1983US4411888 Composition of a novel immunogen for protection against diarrheal disease caused by enterotoxigenic Escherichia coli
10/25/1983CA1155764A2 Detection of non-a, non-b hepatitis associated antigen
10/25/1983CA1155763A1 Vaccine for preventing persistent feline leukemia viremia in cats
10/19/1983EP0091543A1 Anti-interferon antibodies and method of producing same
10/18/1983US4410660 Binding assay for the detection of mycobacteria
10/18/1983US4410510 Method for preparing a purified extraction residue fraction and its use in stimulating the immune response
10/18/1983CA1155393A1 Brucellosis vaccine for cattle containing mycolate esters of trehalose
10/13/1983WO1983003477A1 Blood cell grouping reagent
10/13/1983WO1983003426A1 Magnetic carbohydrate particles as carriers for affinity separation purposes, e.g. cell separation
10/13/1983WO1983003354A1 Neisseria gonorrhoeae vaccine
10/12/1983EP0090966A1 Process for antigen determination
10/12/1983EP0090892A1 Process for the purification of physiologically active substance having antitumour activity
10/12/1983EP0090886A2 Stabilization of influenza virus vaccine
10/11/1983US4409105 Dried, sterilized, gamma-globulin-fixed column and a process for preparing the same
10/11/1983CA1155057A1 Vaccine and method of making
10/11/1983CA1155056A1 Vaccine for the prevention and treatment of bovine mastitis
10/11/1983CA1155055A1 Modified living canine parvovirus vaccine
10/05/1983EP0090732A1 Proteic product, its obtention and use as a medicament, in particular an immuno regulator and anti-allergic agent
10/05/1983EP0090660A2 Neisseria gonorrhoeae vaccine
10/05/1983EP0090581A2 Small peptides with the specificity of foot and mouth disease viral antigens
10/05/1983EP0090359A2 Method for the determination of an allergy and method for the specific determination of the allergen responsible for the allergy
10/05/1983EP0090343A2 Hybrid cell, process for preparaing it and its use
10/04/1983US4407965 Process for preparing antibody
10/04/1983US4407949 High molecular weight polysaccharide from hemophilus
10/04/1983US4407796 Immunology
10/04/1983CA1154673A1 Injectable rabies vaccine composition and method for preparing same
10/04/1983CA1154670A1 Process for testing for the inactivation of vaccines, the harmlessness of blood products and the effectiveness of chemotherapeutic agents and disinfectants against viral hepatitis
09/1983
09/29/1983WO1983003307A1 Method for production of antiserum against granula fraction from endocrinologically active cells
09/29/1983WO1983003306A1 Method and composition for free ligand assays
09/29/1983WO1983003200A1 Cytotoxic medicines including at least an immunotoxine and an amine
09/29/1983WO1983003199A1 Method for obtaining reduced infectivity variants from protozoan parasites, thus obtained variants and utilization thereof
09/28/1983EP0089880A1 Covalent conjugates of an enzyme and an antibody, and medicinal compositions containing these conjugates
09/28/1983EP0089854A2 Vaccine against DNA viruses
09/28/1983EP0089598A1 Anti-streptolysin O-latex reagent and process for its production
09/27/1983US4406890 Immunology; potentiation; stimulants
09/27/1983US4406885 Preparation of native oncornavirus envelope subunits and vaccines therefrom
09/27/1983CA1154438A1 Protein pp in15 xx, a process for its preparation and its use
09/27/1983CA1154437A1 Protein, pp in11 xx, a process for its preparation and its use
09/27/1983CA1154382A1 Vaccine and method of making
09/21/1983EP0089290A1 Conjugates of haptenes and muramyl peptides having an immunogenic activity, and compositions containing them
09/21/1983EP0089283A2 Bacterial toxoids, gram-negative immune globulin therefrom and their preparation
09/21/1983EP0089270A1 Cytotoxic medicines containing at least one immune toxine and one amine
09/21/1983EP0089008A2 Highly specific antiserum against Procollagen-peptide Col 1 (Type III),and Procollagen-peptide (Type III), its preparation and use thereof.
09/21/1983EP0088994A2 Hybrid DNA, binding composition prepared thereby and processes therefor
09/15/1983WO1983003055A1 Cytotixic drug formed by the association of at least one immunotoxine and chloroquine
09/14/1983EP0088695A2 Antibody conjugates
09/14/1983EP0088694A1 Cytotoxic medicine containing at least one immune toxine and chloroquine
09/14/1983EP0088606A2 Monoclonal antibodies against lens epithelial cells
09/14/1983EP0088303A2 Process for the preparation of polysaccharide-protein complexes from bacterial envelopes, products obtained and immunogenic compostions containing them
09/14/1983EP0088302A2 Detoxified neurotoxine of E coli, process to prepare it and immunological compositions containing it
09/13/1983US4404186 Immunizing poultry and mammals against gramnegative bacteria; animal husbandry
09/13/1983CA1153696A1 Extract from plant of genus epimedium sp., process for preparation of said extract, immunostimulating agent comprising said extract as effective component and immunotherapy by using said extract
09/07/1983EP0087735A2 Recombinant DNA, microorganism transformed therewith and their use
09/07/1983EP0087728A1 Immunological latex-agglutination process
09/06/1983US4402939 Vaccinating glycopeptidic antigenic fraction with a very high level of immunogenicity, isolated from cultures of pathogenic germs, processes for isolating said fraction and vaccines containing said fraction
09/06/1983US4402872 Protein and process for isolating it
09/06/1983CA1153310A1 Antigenic composition derived from bacteriodes nodosus
09/06/1983CA1153309A1 Vaccines
09/06/1983CA1153308A1 Preparation of enriched whole virus radioligand
09/01/1983WO1983003008A1 METHOD FOR THE IDENTIFICATION AND PURIFICATION OF HUMAN LUNG TUMOR-ASSOCIATED ANTIGENS (hLTAA) AND CLINICAL DETECTION AND DETERMINATION OF THESE ANTIGENS
09/01/1983WO1983002897A1 Materials and methods for herpes simplex virus vaccination
09/01/1983WO1983002896A1 Method for the purification of parasite antigenic factors
09/01/1983WO1983002895A1 Attenuation of vaccines with monoclonal antibody
08/1983
08/30/1983US4401658 Vaccine adjuvants, immunostimulants
08/30/1983CA1152895A1 Process for the preparation of novel influenza virus strains and influenza virus vaccines containing them
08/24/1983EP0086707A1 DNA fragments encoding for an immunogenic peptide capable of inducing in vivo synthesis of anti-polio virus antibodies
08/24/1983EP0086548A2 A method of cleaving double stranded DNA
08/23/1983US4400472 Novel rabies virus strain and a process for its preparation
08/23/1983US4400376 Immunological preparations
08/23/1983US4400316 C-Terminal fragment of human chorionic gonadotropin
08/23/1983CA1152493A1 Thiolated polypeptide compound derived from a tetanus toxin fragment, the process for obtaining and its applications
08/23/1983CA1152492A1 Reagents for use in binding assays to determine valproic acid
08/23/1983CA1152491A1 Flavin adenine dinucleotide-labeled protein and polypeptide conjugates
08/23/1983CA1152490A1 Beta-galactosyl-umbelliferone-labeled protein and polypeptide conjugates
08/23/1983CA1152431A1 Composition and method for cancer detection in humans
08/18/1983WO1983002725A1 Drugs comprising as association at least one immunotoxin and at least one monovalent carboxylic ionophora
08/18/1983WO1983002456A3 New plasmids and bacterial strains and production process thereof
08/17/1983EP0086152A1 Medicines containing an association of at least one immunotoxine and at least one monovalent carboxylic ionophore
08/17/1983EP0086071A1 Ozone inactivated organisms as vaccines
08/17/1983EP0086025A1 Infectious bronchitis vaccines
08/17/1983EP0085747A2 Intravenously administrable human immunoglobuline and process for its preparation
08/17/1983EP0085693A1 Subjects relating to human inteferon-alpha subtype proteins and corresponding antibodies
08/16/1983US4398382 Method for washing and coating as well as for dosage of EIA-rings and a device for carrying out the method
08/16/1983CA1152014A1 Lactate dehydrogenase mutants of streptococcus mutans
08/16/1983CA1152001A1 Method for producing pertussis toxoid
08/16/1983CA1152000A1 Immunization against dental caries with glucosyltransferase antigens
08/10/1983EP0085469A1 Method of preparing an immunogen of Pasteurella multocida
08/10/1983EP0085362A2 Method for determining allergic sensitivity